Neuland Laboratories Ltd. logo

Neuland Laboratories Ltd. (NEULANDLAB)

Market Closed
7 Aug, 22:00
MSE MSE
22,843. 55
+1,343.6
+6.2493%
- Market Cap
30.06 P/E Ratio
10% Div Yield
12,785 Volume
0 Eps
21,499.95
Previous Close
Add Transaction
Day Range
21,544.2 23,450.75
Year Range
11,500 23,450.75
Want to track NEULANDLAB and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

NEULANDLAB closed Friday higher at ₹22,843.55, an increase of 6.2493% from Thursday's close, completing a monthly increase of 21.6402% or ₹4,063.95. Over the past 12 months, NEULANDLAB stock gained 51.2678%.
NEULANDLAB pays dividends to its shareholders, with the most recent payment made on 1 Hour ago. The next estimated payment will be in 11 Aug 2027 on Aug 11, 2027 for a total of ₹34.
The last earnings report, released on May 13, 2026, exceeded the consensus estimates by 0%. On average, the company has fell short of earnings expectations by -1.4433%, based on the last three reports.
Neuland Laboratories Ltd. has completed 2 stock splits, with the recent split occurring on Aug 13, 2014.
The company's stock is traded on 2 different exchanges and in various currencies, with the primary listing on XNSE (INR).

NEULANDLAB Chart

Neuland Laboratories Ltd. (NEULANDLAB) FAQ

What is the stock price today?

The current price is ₹22,843.55.

On which exchange is it traded?

Neuland Laboratories Ltd. is listed on MSE.

What is its stock symbol?

The ticker symbol is NEULANDLAB.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 10%.

What is its market cap?

As of today, no market cap data is available.

Has Neuland Laboratories Ltd. ever had a stock split?

Neuland Laboratories Ltd. had 2 splits and the recent split was on Aug 13, 2014.

Neuland Laboratories Ltd. Profile

Specialty Retail Industry
Consumer Discretionary Sector
Dr. Davuluri Rama Mohan Rao CEO
MSE Exchange
INE794A01010 ISIN
IN Country
1,794 Employees
24 Jul 2026 Last Dividend
- Last Split
- IPO Date

Overview

Neuland Laboratories Limited is an esteemed manufacturer and global distributor of active pharmaceutical ingredients (APIs), headquartered in Hyderabad, India. Since its inception in 1984, Neuland Laboratories has been at the forefront of producing high-quality APIs for various therapeutic areas, catering to clients in India, the United States, Europe, and other international markets. In addition to its core API production, Neuland Laboratories prides itself on offering specialized custom manufacturing solutions and peptide synthesis services to meet the evolving needs of the pharmaceutical industry.

Products and Services

  • Active Pharmaceutical Ingredients (APIs)

    Neuland Laboratories' portfolio includes APIs used in a wide range of therapeutic fields such as antiasthmatics, cardiovasculars, antifungal, anticonvulsants, central nervous system, fluoroquinolones, antipsychotic, antibacterial, and anti-parkinson diseases. By focusing on these extensive therapeutic areas, Neuland ensures its products meet the diverse needs of healthcare providers and patients globally.

  • Custom Manufacturing Solutions

    Leveraging its extensive expertise in API development and manufacturing, Neuland Laboratories provides tailor-made manufacturing solutions to pharmaceutical companies. These custom services range from the development of unique chemical processes to the scale-up and production of APIs. This flexibility and customization allow Neuland to partner effectively with clients across different stages of drug development and manufacturing.

  • Peptide Synthesis Services

    Understanding the growing importance of peptides in therapeutic applications, Neuland Laboratories offers specialized peptide synthesis services. This service encompasses both the development and the manufacture of peptides using advanced synthesis technologies. Neuland’s capabilities in peptide synthesis enable it to support the pharmaceutical industry's demand for both standard and complex peptides.

Contact Information

Address: Phoenix IVY Building, Hyderabad, India, 500033
Phone: 91 40 6761 1600